No information is available on the influence of ibafloxacin on developing articular cartilage in young cats. As articular cartilage may be affected during this period of rapid growth, ibafloxacin should not be used in cats aged less than 8 months. In dogs, this period depends on the breed.

For the majority of breeds, the use of ibafloxacin is contra-indicated in dogs less than 8 months of age and in giant breeds less than 18 months old.

Diarrhoea, soft faeces, vomiting, dullness, anorexia and salivation were observed with low frequency. These effects were mild and transient.

Heavy reliance on a single class of antibiotic may result in the induction of resistance in a bacterial population. It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions that have responded poorly, or are expected to respond poorly, to other classes of antibiotic. Ibaflin gel should only be used based on susceptibility testing. Do not use in dogs and cats with known quinolone hypersensitivity.

In order to avoid any cross contamination, the same syringe should not be used for different animals. Once a syringe is opened it should only be used to continue the treatment course in the same animal.

The product can be used during pregnancy in dogs. The safety of the veterinary medicinal product has not been established in pregnant cats and in lactating dogs and cats.

Fluoroquinolones should not be used in combination with non-steroidal anti-inflammatory drugs (NSAIDs) in dogs with a history of seizures. Antacids can interfere with gastro-intestinal absorption of quinolones. Antagonism may be observed with nitrofurantoin.

Pyoderma is mostly secondary to an underlying disease. It is advisable to determine the underlying cause and treat the animal accordingly.

Persons with known hypersensitivity to quinolones should avoid contact with the veterinary medicinal product.

For animal treatment only. Keep out of reach of children.